Abstract No. 563 TP53 Mutation Predicts Worse Survival and Earlier Local Recurrence In Hepatocellular Carcinoma Treated with Transarterial Embolization

K. Zhao,L. Kelly,A. Karimi,E. Petre,E. Alexander,V. Sotirchos,B. Marinelli,J. Erinjeri,C. Sofocleous,H. Yarmohammadi,E. Ziv
DOI: https://doi.org/10.1016/j.jvir.2023.12.520
IF: 3.682
2024-02-23
Journal of Vascular and Interventional Radiology
Abstract:To evaluate the association of TP53 mutation with outcomes after transarterial embolization (TAE) of hepatocellular carcinoma (HCC).
radiology, nuclear medicine & medical imaging,peripheral vascular disease
What problem does this paper attempt to address?